Goldman Sachs-backed Aragen Life Sciences on expansion mode, evaluating select acquisition opportunities

Goldman Sachs-backed Aragen Life Sciences on expansion mode, evaluating select acquisition opportunities With revenue of Rs 1,200 crore in the financial year 2021, Aragen provides outsourcing services for drug discovery, clinical trials, and manufacturing to over 450 clients globally, including many large biotech and pharmaceutical companies.

No comments:

Post a Comment